Epilepsy care challenges in developing countries

Current Opinion in Neurology

Volumn 25, Issue 2, 2012, Pages 179-186

  Kvalsund, Michelle P ^a   Birbeck, Gretchen L ^b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Michigan State University   (United States)

^c Chikankata Hospital   (Zambia)

Author keywords

Cost; Developing country; Drug interactions; Epilepsy; HIV; Mortality; Pharmaceutical regulations; Pharmacokinetics; Public policy; Treatment gap

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; ATAZANAVIR PLUS RITONAVIR; EFAVIRENZ; LAMOTRIGINE; LOPINAVIR PLUS RITONAVIR; MIDAZOLAM; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PHENYTOIN; PROTEINASE INHIBITOR; RALTEGRAVIR; VALPROIC ACID; ZIDOVUDINE;

ALGORITHM; BACTERIAL MENINGITIS; BRAIN INJURY; BRAIN MALARIA; CHIKUNGUNYA; CLINICAL TRIAL (TOPIC); COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DENGUE; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE COURSE; DROWNING; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MONITORING; ELECTROENCEPHALOGRAM; ENDEMIC DISEASE; ENVIRONMENTAL FACTOR; EPILEPSY; EPILEPTIC STATE; EVIDENCE BASED PRACTICE; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HEREDITY; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; JAPANESE ENCEPHALITIS; LOWEST INCOME GROUP; MORTALITY; NEUROCYSTICERCOSIS; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZATION AND MANAGEMENT; PARAGONIMIASIS; PATIENT CARE; PATIENT COUNSELING; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RETINOPATHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHISTOSOMIASIS; SEIZURE; SUDDEN DEATH; TOXOCARIASIS; TRADITIONAL MEDICINE; TUBERCULOSIS; VIRUS ENCEPHALITIS; WASTE WATER TREATMENT PLANT; WORLD HEALTH ORGANIZATION;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EPILEPSY; HIV INFECTIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84859775166     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328350baf8     Document Type: Review

References (48)

1. Birbeck GL, Molyneux ME, Kaplan PW, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010; 9:1173-1181.
2. Mu J, Liu L, Zhang Q, et al. Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology 2011; 77:132-137.
3. Birbeck G, Hesdorffer D. The geography of epilepsy: a fatal disease in resource-poor settings. Neurology 2011; 77:96-97.
4. Mental Health Atlas 2011. http://www.whqlibdoc.who.int/publications/2011/ 9799241564359-eng.pdf. [Accessed 4 November 2011]
5. Janca A, Aarli JA, Prilipko L, et al. WHO/WFN survey of neurological services: a worldwide perspective. J Neurol Sci 2006; 247:29-34. (Pubitemid 44107376)
6. Bruckner TA, Scheffler RM, Shen G, et al. The mental health workforce gap in low-and middle-income countries: a needs-based approach. Bull World Health Organ 2011; 89:184-194.
7. WHO. Global Burden of Disease 2010. http://www.who.int/healthinfo/global- burden-disease/GBD-2005-study/en/index.html. [Accessed 4 November 2011]
8. WHO Noncommunicable Diseases and Mental Health. Global status report on noncommunicable diseases. WHO; 2011 http://www.whqlibdoc.who.int/publications/ 2011/9789240686458-eng.pdf. [Accessed 4 November 2011]
9. Birbeck GL. Where did all the other noncommunicable diseases go? BMJ 2011; 343:d5785.
10. Oluwole O. Incidence and risk factors of early posttraumatic seizures in Nigerians. Brain Injury 2011; 25:980-988.
11. Benamer HT, Grosset DG. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia 2009; 50:2301-2304.
12. Singhi P. Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol 2011; 53:600-609.
13. Yemadje LP, Houinato D, Quet F, et al. Understanding the differences in prevalence of epilepsy in tropical regions. Epilepsia 2011; 52:1376-1381.
14. Muto A, Oguni H, Takahashi Y, et al. Nationwide survey (incidence, clinical course, prognosis) of Rasmussen's encephalitis. Brain Dev 2011; 32:445-453.
15. Anga G, Barnabas R, Kaminiel O, et al. The aetiology, clinical presentations and outcome of febrile encephalopathy in children in Papua New Guinea. Ann Trop Paediatr 2011; 30:109-118.
16. Lee YS, Quek SC, Koay ES, et al. Chikungunya mimicking atypical Kawasaki disease in an infant. Pediatr Infect Dis J 2011; 29:275-277.
17. Nkouawa A, Sako Y, Itoh S, et al. Serological studies of neurologic helminthic infections in rural areas of southwest Cameroon: toxocariasis, cysticercosis and paragonimiasis. PLoS Negl Trop Dis 2011; 4:e732.
18. Willingham AL 3rd, Wu HW, Conlan J, et al. Combating Taenia solium cysticercosis in Southeast Asia an opportunity for improving human health and livestock production. Adv Parasitol 2011; 72:235-266.
19. Wu L, Wu M, Tian D, et al. Clinical and imaging characteristics of cerebral schistosomiasis. Cell Biochem Biophys 2011. [Epub ahead of print]
20. Blocher J, Schmutzhard E, Wilkins PP, et al. A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS Negl Trop Dis 2011; 5:e1185.
21. Carabin H, Ndimubanzi PC, Budke CM, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 2011; 5:e1152.
22. Goel D, Dhanai JS, Agarwal A, et al. Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian community. Neurol India 2011; 59:37-40.
23. Bruneau N, Szepetowski P. The role of the urokinase receptor in epilepsy, in disorders of language, cognition, communication and behavior, and in the central nervous system. Curr Pharm Des 2011; 17:1914-1923.
24. Birbeck GL, Beare N, Lewallen S, et al. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am J Trop Med Hyg 2010; 82:231-234.
25. Duggan MB. Epilepsy in rural Ugandan children: seizure pattern, age of onset and associated findings. Afr Health Sci 2011; 10:218-225.
26. Dulac O. Cerebral malaria and epilepsy. Lancet Neurol 2011; 9:1144-1145.
27. Idro R, Kakooza-Mwesige A, Balyejjussa S, et al. Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes 2011; 3:104.
28. Idro R, Marsh K, John CC, et al. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res 2011; 68:267-274
29. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000; 94(Suppl 1):S1-S90.
30. Postels DG, Birbeck GL. Children with retinopathy-negative cerebral malaria: a pathophysiologic puzzle. Pediatr Infect Dis J 2011; 30:953-956.
31. White VA. Malaria in Malawi: inside a research autopsy study of pediatric cerebral malaria. Arch Pathol Lab Med 2011; 135:220-226.
32. Beare NA, Lewallen S, Taylor TE, et al. Redefining cerebral malaria by including malaria retinopathy. Future Microbiol 2011; 6:349-355.
33. Meyer AC, Dua T, Ma J, et al. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010; 88:260-266.
34. BirbeckG,Chomba E,AtadzhanovM,etal. Evidence-based guidelines for EEG utilization at the University Teaching Hospital (UTH). Med J Zambia (in press).
35. WHO. mhGAP: Scaling up care for mental, neurological, and substance use disorders. In: WHO, editor. 2011. http://www.who.int/mental-health/mhgap-final- english.pdf. [Accessed 4 November 2011]
36. Chomba EN, Haworth A, Mbewe E, et al. The current availability of anti-epileptic drugs in Zambia: implications for the ILAE/WHO 'out of the shadows' campaign. Am J Trop Med Hyg 2010; 83:571-574.
37. Rafael F, Houinato D, Nubukpo P, et al. Sociocultural and psychological features of perceived stigma reported by people with epilepsy in Benin. Epilepsia 2011; 51:1061-1068.
38. Babikar HE, Abbas IM. Knowledge, practice and attitude toward epilepsy among primary and secondary school teachers in South Gezira locality, Gezira State, Sudan. J Family Community Med 2011; 18:17-21.
39. Cavanna AE, Cavanna S, Cavanna A. Epileptic seizures and spirit possession in Haitian culture: report of four cases and review of the literature. Epilepsy Behav 2011; 19:89-91.
40. Njamnshi AK, Bissek AC, Yepnjio FN, et al.A community survey of knowledge, perceptions, and practice with respect to epilepsy among traditional healers in the Batibo Health District, Cameroon. Epilepsy Behav 2011; 17:95-102.
41. Osungbade KO, Siyanbade SL. Myths, misconceptions, and misunderstandings about epilepsy in a Nigerian rural community: Implications for community health interventions. Epilepsy Behav 2011; 21:425-429.
42. Barennes H, Sengkhamyong K, Sambany EM, et al. Children's access to treatment for epilepsy: experience from the Lao People's Democratic Republic. Arch Dis Child 2011; 96:309-313.
43. Iyer RS, Rekha M, Kumar TS, et al. Primary care doctors' management behavior with respect to epilepsy in Kerala, southern India. Epilepsy Behav 2011; 21:137-142.
44. Birbeck G. Ou il n'y pas de Neurologie. World Federation Neurol 2011. http://neurology.msu.edu/downloads/where%20there%20is%20no%20neuro logist-whole%20book.pdf. [Accessed 8 November 2011]
45. Odermatt P, Ly S, Simmala C, et al. Availability and costs of antiepileptic drugs and quality of phenobarbital in Vientiane municipality, Lao PDR. Neuro-epidemiology 2007; 28:169-174. (Pubitemid 47344339)
46. Mac TL, Le VT, Vu AN, et al. AEDs availability and professional practices in delivery outlets in a city center in southern Vietnam. Epilepsia 2006; 47:330-334.
47. Birbeck GL. Epilepsy care in developing countries: part I of II. Epilepsy Curr 2010; 10:75-79.
48. Birbeck G, French J, Perucca E, et al. Evidence-based guideline: antiepileptic drug selection for people with HIV/AIDS. Neurology 2012; 78:139-145.